Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score

The utility of the venous thromboembolism (VTE) risk assessment model known as the Khorana Risk Score (KRS) in patients with lymphoid malignancies receiving outpatient chemotherapy is not defined. We evaluated the association of the KRS with VTE in patients treated for diffuse large B cell lymphoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Rupa-Matysek, Joanna, Gil, Lidia, Kaźmierczak, Maciej, Barańska, Marta, Komarnicki, Mieczysław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717131/
https://www.ncbi.nlm.nih.gov/pubmed/29209847
http://dx.doi.org/10.1007/s12032-017-1065-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717131/
https://www.ncbi.nlm.nih.gov/pubmed/29209847
http://dx.doi.org/10.1007/s12032-017-1065-4

Ejemplares similares